Herman Staats

Duke University

$14,034,910

Attributed

$14,034,910

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3.4M · FY2014–25

$5M$3.8M$2.5M$1.3M$0

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$14,034,910 · 3

By mechanism

N01$14,034,910 · 3

Top collaborators

No co-investigators on record.

Most similar at Duke University

Same institution · by research overlap

Herman F. Staats$31,192,841
Gowthami M Arepally$11,531,413
Stuart M Levitz$22,736,478
Barton F Haynes$531,570,874
Gregory D Sempowski$25,654,938

Others in their field

Top investigators on “In Vivo”

David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
Dennis R. Burton · Scripps Research Institute$212,708,174
Mark S Klempner · Tufts Medical Center$128,021,180
Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200

Research focus

In VivoIn VitroProgramsAdjuvantVaccinesCellsContractorAnimal ModelPathogenNational Institute Of Allergy And Infectious DiseaseVaccine CandidateContractsLeadLibrariesEmerging Communicable DiseasesValidationSignal PathwayPharmaceutical ChemistryReceptorStructure-Activity RelationshipMast CellHigh Throughput ScreeningVaccine AdjuvantFingerprint